• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, August 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

One in 6 women diagnosed with breast cancer have a symptom other than a lump

Bioengineer by Bioengineer
November 8, 2016
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

AROUND one in six women (17 per cent) diagnosed with breast cancer go to their doctor with a symptom other than a lump – the most commonly reported breast cancer symptom – according to new research* presented at the 2016 National Cancer Research Institute (NCRI) Cancer conference in Liverpool.

Breast symptoms, other than a breast lump, that may be a sign of cancer (termed 'non-lump' in the study) include nipple abnormalities, breast pain, skin abnormalities, ulceration, shape abnormalities and an infected or inflamed breast.

Researchers from UCL examined the data of more than 2,300 women diagnosed with breast cancer in England in 2009/10. They found that, although most women with breast cancer sought help quickly, those with 'non-lump' symptoms were more likely to delay going to their doctor compared with women with a breast lump alone.

Women with both a breast lump and 'non-lump' symptoms were also more likely to delay seeking help.

Women presenting with breast ulceration, nipple abnormalities, breast infection or inflammation, swollen arm or armpit, and pain in the armpit were more likely to wait longer than three months to seek help.

The research used data from 2009/10 National Audit of Cancer Diagnosis in Primary Care.

There are more than 53,600 breast cancers diagnosed in the UK every year and 11,400 deaths from the disease annually.

Monica Koo, presenting author based at UCL, said: "Our research shows around one in six women diagnosed with breast cancer have symptoms other than a breast lump. These women are more likely to delay going to the doctor compared to women with breast lump alone."

"It's crucial that women are aware that a lump is not the only symptom of breast cancer. If they are worried about any breast symptoms, the best thing to do is to get it checked by a doctor as soon as possible. Diagnosing cancer earlier really is key in order to increase the chances of survival. Symptom awareness campaigns such as the Be Clear on Cancer campaign should continue to emphasise breast symptoms other than breast lump."

Dr Karen Kennedy, Director of the NCRI, said: "This research shows that, all too often, women are delaying going to their doctor with symptoms of breast cancer. This could be because people are simply unaware that breast cancer can present in many different ways, not just through the presence of a lump. With a disease like breast cancer, it's essential to be diagnosed as early as possible so that a treatment plan can be developed and started. Awareness campaigns need to raise awareness of all of the potential symptoms of breast cancer so that people know how to spot the signs and when to go to a doctor."

###

Media Contact

Fiona Dennehy
[email protected]
@CR_UK

http://www.cancerresearchuk.org

Share12Tweet8Share2ShareShareShare2

Related Posts

Pathogenic MECP2 Variants Reveal Broader Neurological Spectrum Beyond Rett Syndrome

August 26, 2026

Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification

August 26, 2026

Updated: eribulin versus taxanes with trastuzumab-pertuzumab for first-line advanced breast cancer

August 26, 2026

Air-Treated Bamboo Yields Balanced-Pore Activated Carbon for Toluene Removal

August 26, 2026
Please login to join discussion

POPULAR NEWS

  • Pathogenic MECP2 Variants Reveal Broader Neurological Spectrum Beyond Rett Syndrome

    29 shares
    Share 12 Tweet 7
  • Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification

    29 shares
    Share 12 Tweet 7
  • Updated: eribulin versus taxanes with trastuzumab-pertuzumab for first-line advanced breast cancer

    29 shares
    Share 12 Tweet 7
  • Air-Treated Bamboo Yields Balanced-Pore Activated Carbon for Toluene Removal

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Pathogenic MECP2 Variants Reveal Broader Neurological Spectrum Beyond Rett Syndrome

Immune-toxicity model and efficacy biomarkers enable precise NSCLC immunotherapy stratification

Updated: eribulin versus taxanes with trastuzumab-pertuzumab for first-line advanced breast cancer

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.